HuGE Literature Finder
Records
1
-
30
| Characteristics of familial pancreatic cancer families with additional colorectal carcinoma. Familial cancer 2023 1 . Lehman Bettina, Matthäi Elvira, Gercke Norman, Denzer Ulrike W, Figiel Jens, Hess Timo, Slater Emily P, Bartsch Detlef |
| Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan. HPB : the official journal of the International Hepato Pancreato Biliary Association 2022 Sep . Muhammad Noor, Sadaqat Rida, Naeemi Humaira, Masood Iqra, Hassan Usman, Ijaz Bushra, Hanif Faisal, Syed Aamir A, Yusuf Muhammed A, Rashid Muhammad |
| A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Environmental and molecular mutagenesis 2022 Jul 63 (6): 308-316. Shao Changxia, Wan Jun, Lam Fred C, Tang Huilin, Marley Andrew R, Song Yiqing, Miller Chelsey, Brown Madeline, Han Jiali, Adeboyeje Gboye |
| A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. Cancers 2022 Jul 14 (13): . Astiazaran-Symonds Esteban, Kim Jung, Haley Jeremy S, Kim Sun Young, Rao H Shanker, Genetics Center Regeneron, Carey David J, Stewart Douglas R, Goldstein Alisa |
| A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. HGG advances 2022 Jan 3 (1): 100078. Yu Yao, Chang Kyle, Chen Jiun-Sheng, Bohlender Ryan J, Fowler Jerry, Zhang Di, Huang Maosheng, Chang Ping, Li Yanan, Wong Justin, Wang Huamin, Gu Jian, Wu Xifeng, Schildkraut Joellen, Cannon-Albright Lisa, Ye Yuanqing, Zhao Hua, Hildebrandt Michelle A T, Permuth Jennifer B, Li Donghui, Scheet Paul, Huff Chad |
| A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial). Annals of surgical oncology 2022 6 29 (9): 5375-5376. Teke Martha E, Saif Areeba, Ryan Carrie E, Lux Stephanie C, Hernandez Jonathan M, Reiss Kim |
| Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients. Journal of Cancer 2022 3 13 (4): 1119-1129. Zong Hong, Zhang Jian, Xu Zhengyang, Pan Jia-Ni, Wang Rong, Han Jinming, Jiang Miao, Ren Ruiping, Zang Li, Wang Haitao, Cao Wen-Mi |
| Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers. American journal of clinical oncology 2022 3 45 (4): 137-141. Tan Elaine, Whiting Junmin, Knepper Todd, Xie Hao, Imanirad Iman, Carballido Estrella, Felder Seth, Frakes Jessica, Mo Qianxing, Permuth Jennifer B, Somerer Katelyn, Kim Richard, Anaya Daniel A, Fleming Jason B, Walko Christine, Sahin Ibrahim |
| Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib. Biomedicines 2022 11 10 (11): . Botrus Gehan, Roe Denise, Jameson Gayle S, Junior Pedro Luiz Serrano Uson, Korn Ronald Lee, Caldwell Lana, Bargenquast Taylor, Miller Max, Borazanci Erkut Has |
| Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
| Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. JAMA network open 2022 02 5 (2): e2148721. Yin Lingdi, Wei Jishu, Lu Zipeng, Huang Shimeng, Gao Hao, Chen Jianmin, Guo Feng, Tu Min, Xiao Bin, Xi Chunhua, Zhang Kai, Li Qiang, Wu Junli, Gao Wentao, Jiang Kuirong, Yu Jun, Miao |
| Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries. JCO precision oncology 2022 2 2 1-16. Smith Alyssa L, Wong Cavin, Cuggia Adeline, Borgida Ayelet, Holter Spring, Hall Anita, Connor Ashton A, Bascuñana Claire, Asselah Jamil, Bouganim Nathaniel, Poulin Véronique, Jolivet Jacques, Vafiadis Petro, Le Philippe, Martel Guillaume, Lemay Frédéric, Beaudoin Annie, Rafatzand Khashayar, Chaudhury Prosanto, Barkun Jeffrey, Metrakos Peter, Marcus Victoria, Omeroglu Atilla, Chong George, Akbari Mohammad R, Foulkes William D, Gallinger Steven, Zogopoulos Geor |
| Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study. Clinical and translational gastroenterology 2021 Oct 12 (10): e00414. Uson Pedro L S, Samadder N Jewel, Riegert-Johnson Douglas, Boardman Lisa, Borad Mitesh J, Ahn Daniel, Sonbol Mohamad B, Faigel Douglas O, Fukami Norio, Pannala Rahul, Kunze Katie, Golafshar Michael, Klint Margaret, Esplin Edward D, Nussbaum Robert L, Stewart A Keith, Bekaii-Saab Tani |
| Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer prevention research (Philadelphia, Pa.) 2021 Oct . Furniss C Sloane, Yurgelun Matthew B, Ukaegbu Chinedu, Constantinou Pamela E, Lafferty Catherine C, Talcove-Berko Eliana R, Schwartz Alison N, Stopfer Jill E, Underhill-Blazey Meghan, Kenner Barbara, Nelson Scott H, Okumura Sydney, Law Sherman, Zhou Alicia Y, Coffin Tara B, Rodriguez Nicolette J, Uno Hajime, Ocean Allyson J, McAllister Florencia, Lowy Andrew M, Lippman Scott M, Klein Alison P, Madlensky Lisa, Petersen Gloria M, Garber Judy E, Goggins Michael G, Maitra Anirban, Syngal Sap |
| Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in genetics 2021 12 12 674094. Su Yifan, Yao Qianlan, Xu Yuyin, Yu Chengli, Zhang Jing, Wang Qian, Li Jiwei, Shi Di, Yu Baohua, Zeng Yupeng, Zhu Xiaoli, Bai Qianming, Zhou Xiaoy |
| Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer. Journal of personalized medicine 2021 8 11 (7): . Slater Emily P, Wilke Lisa M, Böhm Lutz Benedikt, Strauch Konstantin, Lutz Manuel, Gercke Norman, Matthäi Elvira, Hemminki Kari, Försti Asta, Schlesner Matthias, Paramasivam Nagarajan, Bartsch Detlef |
| Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population. Annals of gastroenterological surgery 2021 11 5 (6): 853-864. Hata Tatsuo, Mizuma Masamichi, Motoi Fuyuhiko, Ishida Masaharu, Ohtsuka Hideo, Nakagawa Kei, Morikawa Takanori, Furukawa Toru, Unno Michia |
| Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis. PloS one 2021 2 16 (2): e0247363. Sandoval Renata Lazari, Leite Ana Carolina Rathsam, Barbalho Daniel Meirelles, Assad Daniele Xavier, Barroso Romualdo, Polidorio Natalia, Dos Anjos Carlos Henrique, de Miranda Andréa Discaciati, Ferreira Ana Carolina Salles de Mendonça, Fernandes Gustavo Dos Santos, Achatz Maria Isab |
| Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants. Hereditary cancer in clinical practice 2021 8 19 (1): 33. Murali Krithika, Dwarte Tanya M, Nikfarjam Mehrdad, Tucker Katherine M, Vaughan Rhys B, Efthymiou Marios, Collins Allison, Spigelman Allan D, Salmon Lucinda, Johns Amber L, Williams David B, Delatycki Martin B, John Thomas, Stoita Ali |
| Frequency and molecular characteristics of PALB2-associated cancers in Russian patients. International journal of cancer 2020 9 148 (1): 203-210. Preobrazhenskaya Elena V, Shleykina Alla U, Gorustovich Olga A, Martianov Alexandr S, Bizin Ilya V, Anisimova Elena I, Sokolova Tatjana N, Chuinyshena Svetlana A, Kuligina Ekatherina Sh, Togo Alexandr V, Belyaev Alexey M, Ivantsov Alexandr O, Sokolenko Anna P, Imyanitov Evgeny |
| The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response. Human mutation 2020 11 42 (2): 150-163. Zhang Yue, Park Jung-Young, Zhang Fan, Olson Sara H, Orlow Irene, Li Yirong, Kurtz Robert C, Ladanyi Marc, Chen Jie, Toland Amanda E, Zhang Liying, Andreassen Paul |
| Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Dec . Goldstein Jennifer B, Zhao Li, Wang Xuemei, Ghelman Yael, Overman Michael J, Javle Milind M, Shroff Rachna T, Varadhachary Gauri R, Wolff Robert A, McAllister Florencia, Futreal Andrew, Fogelman David |
| Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Mar JCO1801512. Abe Toshiya, Blackford Amanda L, Tamura Koji, Ford Madeline, McCormick Patrick, Chuidian Miguel, Almario Jose Alejandro, Borges Michael, Lennon Anne Marie, Shin Eun Ji, Klein Alison P, Hruban Ralph H, Canto Marcia I, Goggins Micha |
| Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 12 38 (7): 674-685. Yang Xin, Leslie Goska, Doroszuk Alicja, Schneider Sandra, Allen Jamie, Decker Brennan, Dunning Alison M, Redman James, Scarth James, Plaskocinska Inga, Luccarini Craig, Shah Mitul, Pooley Karen, Dorling Leila, Lee Andrew, Adank Muriel A, Adlard Julian, Aittomäki Kristiina, Andrulis Irene L, Ang Peter, Barwell Julian, Bernstein Jonine L, Bobolis Kristie, Borg Åke, Blomqvist Carl, Claes Kathleen B M, Concannon Patrick, Cuggia Adeline, Culver Julie O, Damiola Francesca, de Pauw Antoine, Diez Orland, Dolinsky Jill S, Domchek Susan M, Engel Christoph, Evans D Gareth, Fostira Florentia, Garber Judy, Golmard Lisa, Goode Ellen L, Gruber Stephen B, Hahnen Eric, Hake Christopher, Heikkinen Tuomas, Hurley Judith E, Janavicius Ramunas, Kleibl Zdenek, Kleiblova Petra, Konstantopoulou Irene, Kvist Anders, Laduca Holly, Lee Ann S G, Lesueur Fabienne, Maher Eamonn R, Mannermaa Arto, Manoukian Siranoush, McFarland Rachel, McKinnon Wendy, Meindl Alfons, Metcalfe Kelly, Mohd Taib Nur Aishah, Moilanen Jukka, Nathanson Katherine L, Neuhausen Susan, Ng Pei Sze, Nguyen-Dumont Tu, Nielsen Sarah M, Obermair Florian, Offit Kenneth, Olopade Olufunmilayo I, Ottini Laura, Penkert Judith, Pylkäs Katri, Radice Paolo, Ramus Susan J, Rudaitis Vilius, Side Lucy, Silva-Smith Rachel, Silvestri Valentina, Skytte Anne-Bine, Slavin Thomas, Soukupova Jana, Tondini Carlo, Trainer Alison H, Unzeitig Gary, Usha Lydia, van Overeem Hansen Thomas, Whitworth James, Wood Marie, Yip Cheng Har, Yoon Sook-Yee, Yussuf Amal, Zogopoulos George, Goldgar David, Hopper John L, Chenevix-Trench Georgia, Pharoah Paul, George Sophia H L, Balmaña Judith, Houdayer Claude, James Paul, El-Haffaf Zaki, Ehrencrona Hans, Janatova Marketa, Peterlongo Paolo, Nevanlinna Heli, Schmutzler Rita, Teo Soo-Hwang, Robson Mark, Pal Tuya, Couch Fergus, Weitzel Jeffrey N, Elliott Aaron, Southey Melissa, Winqvist Robert, Easton Douglas F, Foulkes William D, Antoniou Antonis C, Tischkowitz Ma |
| De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer. Familial cancer 2019 12 19 (2): 193-196. Bernstein Molho Rinat, Zalmanoviz Shelly, Laitman Yael, Friedman Eit |
| Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. Oncotarget 2018 Apr 9 (28): 19817-19825. Kondo Tomohiro, Kanai Masashi, Kou Tadayuki, Sakuma Tomohiro, Mochizuki Hiroaki, Kamada Mayumi, Nakatsui Masahiko, Uza Norimitsu, Kodama Yuzo, Masui Toshihiko, Takaori Kyoichi, Matsumoto Shigemi, Miyake Hidehiko, Okuno Yasushi, Muto Mana |
| Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms. Journal of the National Cancer Institute 2018 Feb . Lowery Maeve A, Wong Winston, Jordan Emmet J, Lee Jonathan W, Kemel Yelena, Vijai Joseph, Mandelker Diana, Zehir Ahmet, Capanu Marinela, Salo-Mullen Erin, Arnold Angela G, Yu Kenneth H, Varghese Anna M, Kelsen David P, Brenner Robin, Kaufmann Erica, Ravichandran Vignesh, Mukherjee Semanti, Berger Michael F, Hyman David M, Klimstra David S, Abou-Alfa Ghassan K, Tjan Catherine, Covington Christina, Maynard Hannah, Allen Peter J, Askan Gokce, Leach Steven D, Iacobuzio-Donahue Christine A, Robson Mark E, Offit Kenneth, Stadler Zsofia K, O'Reilly Eileen |
| Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 8 24 (24): 6204-6211. Sehdev Amikar, Gbolahan Olumide, Hancock Brad A, Stanley Melissa, Shahda Safi, Wan Jun, Wu Howard H, Radovich Milan, O'Neil Bert |
| Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 8 35 (30): 3382-3390. Shindo Koji, Yu Jun, Suenaga Masaya, Fesharakizadeh Shahriar, Cho Christy, Macgregor-Das Anne, Siddiqui Abdulrehman, Witmer P Dane, Tamura Koji, Song Tae Jun, Navarro Almario Jose Alejandro, Brant Aaron, Borges Michael, Ford Madeline, Barkley Thomas, He Jin, Weiss Matthew J, Wolfgang Christopher L, Roberts Nicholas J, Hruban Ralph H, Klein Alison P, Goggins Micha |
| Germline mutations in pancreatic cancer and potential new therapeutic options. Oncotarget 2017 10 8 (42): 73240-73257. Pihlak Rille, Valle Juan W, McNamara Mairéad |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: